Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 55
- Uncategorized
New York’s Illicit Cannabis Raids Challenged in Court, This Time by NYC Police
New York’s ongoing efforts to clamp down on the state’s thriving illicit cannabis market are being challenged in the courts once again, but this time by the state’s police forces.
- Companies
Allied Corp Expands in to Europe as It Hopes to Shift Perceptions Around Colombian Cannabis
Canadian cannabis supplier Allied Corp has further expanded its foothold in Europe’s blooming medical cannabis industry, signing a new five-year forward purchase agreement in Poland.
- Uncategorized
New Jersey Hemp Industry Mired in Confusion and Uncertainty Following Court Ruling
New Jersey’s hemp industry has been left in limbo as the state cannabis regulator announced it would enforce some, but not all, of the new measures to ban the sale of intoxicating hemp products.
- Uncategorized
The Hidden Costs of Cannabis Legalization: What About the Patients?
Writing for Business of Cannabis, Deborah Tharp, a cannabis-focused political consultant, campaign manager and legal researcher for Nugg and NuggMD, explains why it’s more crucial than ever not to overlook the stark differences between medical and recreational cannabis use.
- Medical
German Doctors Can Now Prescribe Reimbursed Medical Cannabis Without Prior Approval, But Cannabis Sentiment Wanes
From October 17, the majority of doctors in Germany will be able to prescribe medical cannabis for reimbursement without securing prior approval of the health insurance companies.
- Press releases
New Zealand’s Helius Therapeutics Launches in Australia
New Zealand’s largest producer of medicinal cannabis, Helius Therapeutics, has launched in the Australian market under the brand HTL.
- Uncategorized
RIV Capital Signs Distribution Deal With Nabis to Expand in to New York Market
RIV Capital has signed a new distribution agreement with Nabis, enabling it to expand its reach in New York’s flourishing legal cannabis market.
- Markets & Stocks
Voyager Life Offloads Cannabis Operations, Stenocare Drops Sales Guidance for a Second Time, & More from Cantourage
Voyager Life [stock_market_widget type=”chart” template=”line” assets=”VOY.AQ” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Voyager Life, which recently rebranded as Mendell Helium, has announced the sale of its cannabis-facing business after first announcing its intention to exit the space in June.
- Uncategorized
California Judge Rejects Legal Efforts to Block Controversial Hemp Ban
Efforts to stall the controversial ban on hemp products in California have been rejected by a court judge, who called requests for a temporary restraining order (TRO) a ‘drastic remedy’.
- Uncategorized
New York Launches Loan Fund Offering Small Cannabis Businesses up to $100,000
New York’s Conditional Adult-Use Retail Dispensaries (CAURD) licensees will now have access to loans of up to $100,000 in a push to give the ‘intended beneficiaries of the new market… the resources they need to truly succeed’.
- Uncategorized
Harris Pledges to Federally Legalize Adult-Use Cannabis Marking ‘Essential Turning Point in US Drug Policy’
Presidential hopeful Kamala Harris has pledged to federally legalize cannabis if she wins the upcoming election in November, marking a major positive shift for cannabis reform in the US.
- Uncategorized
Campaign to Overturn Federal Cannabis Prohibition Rebuffed for a Second Time by DOJ
Last week, the US Department of Justice (DOJ) instructed a federal appeals court to uphold a nationwide ban on cannabis, throwing efforts to overturn federal prohibition into doubt.











